Ambry

PHOENIX (GenomeWeb News) – Whole-exome sequencing is inching its way into the clinic, and at the American College of Medical Genetics and Genomics annual meeting held here geneticists and clinicians showed how such sequencing could be used to find diagnoses for patients whose conditions had remai

With 10,000 next-generation sequencing-based diagnostic tests performed since 2010, including more than 1,000 exome sequencing tests, Ambry Genetics plans to develop additional panels in the areas of rare disease and oncology, and expand some of its existing panels.

NEW YORK (GenomeWeb News) – Exact Sciences said in its 10-K filing with the US Securities and Exchange Commission this week that in December it entered into an amendment to a licensing agreement pursuant to which Hologic granted the company a non-exclusive worldwide license to certain Hologic pat

Agilent Technologies and PerkinElmer have signed an agreement that will see PerkinElmer's Signature Genomics business switch to Agilent arrays for its genetic testing services.

This story has been updated to include comments from a Roche NimbleGen service provider and a Roche spokesperson.

Early adopters of clinical sequencing are all taking slightly different approaches — from whole-genome sequencing to exome sequencing to targeted panels — but one of the key hurdles they all face is interpretation and analysis, according to speakers at Cambridge Healthtech Instit

This article has been updated from a previous version to include market research information about Fluidigm from DeciBio.

This story was originally posted on April 20.

Ambry Genetics said today that it has launched genomic research services based on Fluidigm's BioMark HD and Access Array systems.

Pages

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.